Abstract
Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor, which is important for neuronal survival, development and synaptic plasticity. Accumulating evidence suggests that epigenetic modifications of BDNF are associated with the pathophysiology of psychiatric disorders, such as schizophrenia and mood disorders. Patients with psychiatric disorders generally show decreased neural BDNF levels, which are often associated with increased DNA methylation at the specific BDNF promoters. Importantly, observed DNA methylation changes are consistent across tissues including brain and peripheral blood, which suggests potential usefulness of these findings as a biomarker of psychiatric disorders. Here we review DNA methylation characteristics of BDNF promoters of cellular, animal and clinical samples and discuss future perspectives. © 2013 The Japan Society of Human Genetics All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Ikegame, T., Bundo, M., Murata, Y., Kasai, K., Kato, T., & Iwamoto, K. (2013, July). DNA methylation of the BDNF gene and its relevance to psychiatric disorders. Journal of Human Genetics. https://doi.org/10.1038/jhg.2013.65
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.